H Y Kwon1, B R Kim2,3, Y W Kim1,4. 1. Division of Colorectal Surgery, Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, R.O.K. 2. Health Promotion Center, Wonju Severance Christian Hospital, Wonju, R.O.K. 3. Division of Gastroenterology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, R.O.K. 4. Big Data Research Group, Yonsei University Wonju College of Medicine, Wonju, R.O.K.
Abstract
Background: We investigated whether preoperative anemia and perioperative blood transfusion (pbt) are associated with overall survival and recurrence-free survival in patients with nonmetastatic colorectal cancer. Methods: From 1 January 2009 to 31 December 2014, 1003 patients with primary colorectal cancer were enrolled in the study. Perioperative clinical and oncologic outcomes were analyzed based on the presence of preoperative anemia and pbt. Results: Preoperative anemia was found in 468 patients (46.7%). In the anemia and no-anemia groups, pbt was performed in 44% and 15% of patients respectively. Independent predictors for pbt were preoperative anemia, higher American Society of Anesthesiologists score, laparotomy, lengthy operative time, advanced TNM stage, T4 stage, and 30-day morbidity. The use of pbt, but not preoperative anemia, was found to be an independent adverse prognostic factor for overall survival. In terms of recurrence-free survival, the presence of preoperative anemia was similarly not a significant prognostic factor, but the use of pbt was an independent factor for an unfavourable prognosis. Conclusions: The use of pbt, but not preoperative anemia, was independently associated with worse overall and recurrence-free survival in nonmetastatic colorectal cancer. For better oncologic outcomes, our findings indicate a need to reduce the use of blood transfusion during the perioperative period.
Background: We investigated whether preoperative anemia and perioperative blood transfusion (pbt) are associated with overall survival and recurrence-free survival in patients with nonmetastatic colorectal cancer. Methods: From 1 January 2009 to 31 December 2014, 1003 patients with primary colorectal cancer were enrolled in the study. Perioperative clinical and oncologic outcomes were analyzed based on the presence of preoperative anemia and pbt. Results: Preoperative anemia was found in 468 patients (46.7%). In the anemia and no-anemia groups, pbt was performed in 44% and 15% of patients respectively. Independent predictors for pbt were preoperative anemia, higher American Society of Anesthesiologists score, laparotomy, lengthy operative time, advanced TNM stage, T4 stage, and 30-day morbidity. The use of pbt, but not preoperative anemia, was found to be an independent adverse prognostic factor for overall survival. In terms of recurrence-free survival, the presence of preoperative anemia was similarly not a significant prognostic factor, but the use of pbt was an independent factor for an unfavourable prognosis. Conclusions: The use of pbt, but not preoperative anemia, was independently associated with worse overall and recurrence-free survival in nonmetastatic colorectal cancer. For better oncologic outcomes, our findings indicate a need to reduce the use of blood transfusion during the perioperative period.
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: John M McGrane; David J Humes; Austin G Acheson; Fiona Minear; James M D Wheeler; Catherine J Walter Journal: Clin Colorectal Cancer Date: 2017-03-24 Impact factor: 4.481
Authors: Min Sung An; Jong Han Yoo; Kwang Hee Kim; Ki Beom Bae; Chang Soo Choi; Jin Won Hwang; Ji Hyun Kim; Bo Mi Kim; Mi Seon Kang; Min Kyung Oh; Kwan Hee Hong Journal: World J Surg Oncol Date: 2015-02-19 Impact factor: 2.754
Authors: Malin E M Mörner; Gustaf Edgren; Anna Martling; Ulf Gunnarsson; Monika Egenvall Journal: Int J Colorectal Dis Date: 2016-10-21 Impact factor: 2.571
Authors: Marley Ribeiro Feitosa; Lucas Fernandes de Freitas; Antonio Balestrim Filho; Guilherme Seizem Nakiri; Daniel Giansante Abud; Ligia Magnani Landell; Mariângela Ottoboni Brunaldi; Jose Joaquim Ribeiro da Rocha; Omar Feres; Rogério Serafim Parra Journal: World J Clin Oncol Date: 2020-12-24
Authors: Mikael Kangaspunta; Jorma Mäkijärvi; Selja Koskensalo; Arto Kokkola; Perttu Arkkila; Tom Scheinin; Suvi Rasilainen Journal: Int J Colorectal Dis Date: 2021-12-20 Impact factor: 2.571
Authors: Stephanie Garcia-Botello; J Martín-Arevalo; C Cozar-Lozano; A Benitez-Riesco; D Moro-Valdezate; V Pla-Martí; A Espí-Macías Journal: Langenbecks Arch Surg Date: 2021-07-11 Impact factor: 3.445